Mounjaro and Rybelsus both belong to the GLP-1 receptor agonist class of medications, but they differ in how theyre taken, what they treat, and their effectiveness
Semaglutide has since earned FDA approval specifically for weight management under the brand name Wegovy, positioning it as a powerful tool in the fight against obesity
This receptor is found on the beta cells of the pancreas, which also aids in the secretion of insulin by the body after eating
Patients taking GLP-1 drugs lose weight faster, but they may experience side effects, such as nausea, vomiting, diarrhea, indigestion, fatigue, dizziness, and hypoglycemia, along with other potential adverse events
It may also reflect unfamiliarity, bias, fatigue, or simple resistance to being challenged
They might even trigger hypoglycemiaa potentially life-threatening condition where blood sugar drops too low